FULC Historical Earnings image   This FULC historical earnings page last updated 5/15/2024
FULC Historical Revenue
PeriodHistorical Earnings DateGAAP
Q1 20245/13/2024NA
Q4 20232/27/20240.00B
Q3 202311/7/20230.00B
Q2 20238/3/20230.00B
Q1 20235/15/20230.00B
Q4 20223/9/20230.00B
Q3 202211/8/20220.00B
Q2 20228/11/20220.00B
Q1 20225/9/20220.00B
Q4 20213/3/20220.01B
Q3 202111/4/20210.00B
Q2 20218/10/20210.00B
Q1 20215/6/20210.00B
Q4 20203/4/20210.00B
Q3 202011/10/20200.00B
Q2 20208/11/20200.00B
Q1 20205/13/20200.00B
Q4 20193/5/2020NA
Q3 201911/14/2019NA
Q2 20198/26/2019NA
FULC Historical Earnings EPS
PeriodHistorical Earnings DateGAAP
Q1 20245/13/2024-0.430
Q4 20232/27/2024-0.400
Q3 202311/7/2023-0.390
Q2 20238/3/2023-0.380
Q1 20235/15/2023-0.410
Q4 20223/9/2023-0.500
Q3 202211/8/2022-0.510
Q2 20228/11/2022-0.830
Q1 20225/9/2022-0.640
Q4 20213/3/2022-0.580
Q3 202111/4/2021-0.570
Q2 20218/10/2021-0.600
Q1 20215/6/2021-0.540
Q4 20203/4/2021-0.640
Q3 202011/10/2020-0.700
Q2 20208/11/2020-0.660
Q1 20205/13/2020-0.810
Q4 20193/5/2020-0.710
Q3 201911/14/2019-0.970
Q2 20198/26/2019-9.210
Quotes delayed 20 minutes

Email EnvelopeFree FULC Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Fulcrum Therapeutics (FULC) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

FVE Historical Earnings
FWBI Historical Earnings
GALT Historical Earnings
GBIO Historical Earnings
GBT Historical Earnings
GEHC Historical Earnings
GERN Historical Earnings
GH Historical Earnings
GILD Historical Earnings
GKOS Historical Earnings
What was the record high FULC historical earnings result?
In terms of earnings or revenue, what is the best FULC historical earnings result that Fulcrum Therapeutics has ever posted, and when?

✔️Accepted answer: Within our data set, the highest FULC historical earnings result was set in Q2 2023, when Fulcrum Therapeutics posted results of -0.380/share. The most successful revenue quarter within our data set was Q4 2021 when Fulcrum Therapeutics reported revenue of 0.01B.

What was the lowest Fulcrum Therapeutics historical earnings result?
In terms of top line revenue or bottom line earnings per share, what was the lowest FULC has reported, and when?

✔️Accepted answer: Within our data set, the lowest FULC historical earnings result was set in Q2 2019, when Fulcrum Therapeutics posted results of -9.210/share. The smallest revenue quarter within our data set was Q1 2024 when Fulcrum Therapeutics reported revenue of NA.

On this page we presented the FULC historical earnings date information for Fulcrum Therapeutics. Reviewing that FULC Historical Earnings for the company, we see that the highest historical earnings result in our data set was in Q2 2023, when FULC posted gaap of -0.380/share. Meanwhile the lowest FULC historical earnings result was in Q2 2019, when FULC posted gaap of -9.210/share. Moving to Fulcrum Therapeuticss historical revenue numbers, the largest revenue quarter in our data set was seen in Q4 2021 when FULC reported 0.01B in revenue, while the smallest revenue quarter was Q1 2024 when FULC reported NA in revenue.

For self directed investors doing their due diligence on FULC or any other given stock, their research can benefit from looking into all of the Fulcrum Therapeutics historical earnings in our data set presented side by side on one page for ease of comparison. Reviewing this historical EPS information can help when projecting future earnings per share, as well as providing important context for pondering whether the historical earnings trajectory justifies the current stock value or not. That's why we bring you HistoricalEarnings.com to make it more convenient for investors to look into Fulcrum Therapeutics historical earnings, or the historical earnings information for any stock in our coverage universe. In your continued due diligence investigations, we hope you check out the further links included for historical PE studies, earnings surprises history as well as next earnings dates for FULC. Thanks for visiting, and the next time you need to research FULC historical earnings or those of another stock, we hope our site will come to your mind as your preferred historical earnings, revenue, and EPS research resource of choice.

Recommended: Top Ten Hedge Funds Holding BKUI, PRKR Options Chain, Top Ten Hedge Funds Holding DXJF.


FULC Historical Earnings | www.HistoricalEarnings.com | Copyright © 2020 - 2024, All Rights Reserved

Nothing in HistoricalEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
Wait! Don't leave yet.
Want to receive our latest research absolutely free?

Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.